# Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D

> **NCT02607410** · PHASE4 · COMPLETED · sponsor: **University of Sao Paulo General Hospital** · enrollment: 40 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** sitagliptin
- **DRUG:** NPH insulin

## Key facts

- **NCT ID:** NCT02607410
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2012-01
- **Final completion:** 2014-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02607410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02607410, "Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02607410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*